Literature DB >> 15941661

TGF-beta1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosis.

Christoph H Osterreicher1, Christian Datz, Felix Stickel, Claus Hellerbrand, Melitta Penz, Harald Hofer, Fritz Wrba, Edward Penner, Detlef Schuppan, Peter Ferenci.   

Abstract

Hereditary hemochromatosis (HHC) is an autosomal recessive disorder of iron metabolism with variable penetrance. Only a minority of C282Y homozygotes develop clinical overt disease and cirrhosis. The phenotypic heterogeneity of HHC may be due to host genetic factors influencing fibrogenesis such as cytokine gene polymorphisms. In this respect, we investigated the impact of functional genetic polymorphisms of TGF-beta1 (codon 10 Leu/Pro, codon 25 Arg/Pro), TNF-alpha (-308 G/A, -238 G/A) and angiotensinogen (-6 G/A) on the development of cirrhosis in HHC. One hundred and forty-nine (111 male, mean age: 51.0+/-12.9) C282Y homozygotes who underwent liver biopsy were studied. Genotyping was performed by RFLP analysis. TGF-beta1 codon 25 genotypes Arg/Pro and Pro/Pro were more common in patients with cirrhosis than in those without (23.6% vs. 7.4%, p = 0.005). In contrast, the distribution of TGF-beta1 codon 10, TNF-alpha and angiotensinogen genotypes was not different. Logistic regression analysis identified male sex, age, serum ferritin and TGF-beta1 codon 25 Arg/Pro and Pro/Pro as independent predictors for the presence of cirrhosis. The adjusted odds ratio for TGF-beta1 codon 25 Arg/Pro and Pro/Pro was 2.8 (95% CI 1.4-5.7, p = 0.004). In conclusion, C282Y homozygotes carrying TGF-beta1 genotypes Arg/Pro and Pro/Pro are more likely to develop cirrhosis than those with genotype Arg/Arg.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15941661     DOI: 10.1016/j.cyto.2005.03.005

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

Review 1.  Phenotypic expression of hereditary hemochromatosis: what have we learned from the population studies?

Authors:  Eng K Gan; Oyekoya T Ayonrinde; Debbie Trinder; John K Olynyk
Journal:  Curr Gastroenterol Rep       Date:  2010-02

2.  Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis.

Authors:  Marnie J Wood; Lawrie W Powell; Jeannette L Dixon; V Nathan Subramaniam; Grant A Ramm
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 3.  Factors influencing disease phenotype and penetrance in HFE haemochromatosis.

Authors:  J Rochette; G Le Gac; K Lassoued; C Férec; K J H Robson
Journal:  Hum Genet       Date:  2010-07-06       Impact factor: 4.132

4.  Role of transforming growth factor-β1 in serum and - 509 C>T promoter gene polymorphism in development of liver cirrhosis in Egyptian patients.

Authors:  Abeer Mohy; Ahmed Fouad
Journal:  Meta Gene       Date:  2014-09-09

5.  A Meta-Analysis of the Influence of Tumor Necrosis Factor-α-308 Gene Polymorphism on Liver Cirrhosis.

Authors:  Chang Liu; Songtao Yang
Journal:  J Healthc Eng       Date:  2022-03-19       Impact factor: 2.682

6.  Role of host genetics in fibrosis.

Authors:  Georgina L Hold; Paraskevi Untiveros; Karin A Saunders; Emad M El-Omar
Journal:  Fibrogenesis Tissue Repair       Date:  2009-12-04

Review 7.  Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality.

Authors:  O A Gressner; R Weiskirchen; A M Gressner
Journal:  J Cell Mol Med       Date:  2007 Sep-Oct       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.